R&D Trends

Mayo, Sanford-Burnham extend collaborative agreement

Wednesday, March 13, 2013 10:10 AM

Sanford-Burnham Medical Research Institute and the Mayo Clinic signed a new collaborative agreement to build a pipeline of therapeutic drugs aimed at a variety of diseases with serious unmet medical needs.

More... »

Elsevier, ACC launch new journal JACC: Heart Failure

Monday, March 11, 2013 03:03 PM

Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the American College of Cardiology (ACC) have launched a new journal named JACC: Heart Failure. This journal will better meet the demands and challenges of treating what is now the most rapidly increasing category of cardiac disease. The first publication is now available here.

More... »

Report: Biologics research promises to bolster future of medicine

Monday, March 11, 2013 02:01 PM

America's biopharmaceutical companies are using biological processes to develop 907 medicines and vaccines targeting more than 100 diseases, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).

More... »

Progenitor Labs secures $5.8M to progress regenerative medicine platform

Monday, March 11, 2013 11:36 AM

Progenitor Labs, a regenerative medicine company, has raised $5.8 million in seed financing from the U.K. Fund of SR One, GlaxoSmithKline's independent corporate healthcare venture capital fund.

More... »

Galapagos and Roche conclude strategic alliance

Monday, March 11, 2013 10:38 AM

Galapagos, mid-size clinical stage biotechnology company, has agreed with Roche to end their alliance in fibrosis. Roche will make a payment of $975,000 to Galapagos for work completed in 2012, contributing to 2012 group revenues.

More... »

Janssen launches global cardiovascular research program, five new studies

Friday, March 8, 2013 10:47 AM

Janssen Research & Development has launched EXPLORER, a comprehensive, global research program for XARELTO (rivaroxaban), an oral anticoagulant. The program includes studies that will evaluate XARELTO for investigational use in patients with chronic heart failure and in those with coronary artery disease or peripheral artery disease.

More... »

Findings: Treatment-resistant hypertension exerts serious emotional toll on patients

Tuesday, March 5, 2013 04:13 PM

Results from a large, international survey on treatment-resistant hypertension (rHTN) found rHTN has a significant impact on patients' quality of life, having a negative impact on mood, work and interpersonal relationships.

More... »

E.U. to fund $187 million in new research on rare diseases

Tuesday, March 5, 2013 03:56 PM

The European Commission, in honor of Rare Disease Day 2013, has announced $187 million of new funding for 26 research projects on rare diseases. The projects will help improve the lives of some of the 30 million Europeans suffering from a rare disease.

More... »

GNS Healthcare joins Orion Bionetworks to develop predictive models

Monday, March 4, 2013 02:08 PM

GNS Healthcare has joined in the formation of Orion Bionetworks. This unique alliance will work to transform understanding of and accelerate the drug development process for a wide variety of diseases, beginning with multiple sclerosis (MS).

More... »

Top technology gurus join to design mobile phone game to help speed cancer cures

Friday, March 1, 2013 02:30 PM

Cancer Research UK is bringing together its world-leading scientists with technology gurus such as Amazon Web Services, Facebook and Google to design and develop a mobile game to accelerate cures for cancer.

More... »